CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-09 | TAHL CINDY General Counsel and Secretary | Sale 10b5-1 | −24,363 | $2.40 | $58K | 153,235 |
| 2023-08-18 | Dulac Edward J III Chief Financial Officer | Sale | −4,718 | $2.80 | $13K | 119,570 |
| 2023-08-04 | Xu Yuan Director | Sale 10b5-1 | −632 | $3.71 | $2K | 9,302 |
| 2023-07-05 | Powl Brian T. Chief Commercial Officer | Sale | −3,854 | $4.87 | $19K | 41,146 |
| 2023-07-05 | Dulac Edward J III Chief Financial Officer | Sale 10b5-1 | −5,182 | $4.83 | $25K | 124,288 |
| 2023-06-14 | Xu Yuan Director | Sale 10b5-1 | −3,460 | $5.58 | $19K | 9,934 |
| 2023-06-06 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | Xu Yuan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | MENDLEIN JOHN Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | HERSHBERG ROBERT Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | EPSTEIN ROBERT S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | Agarwal Shefali Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-04-21 | Redmile Group, LLC Director | Purchase | +256,639 | $6.18 | $1.6M | 13,135,758 |
| 2023-04-20 | Redmile Group, LLC Director | Purchase | +20,000 | $5.99 | $120K | 12,879,119 |
| 2023-04-18 | Chu Yu-Waye Chief Medical Officer | Sale 10b5-1 | −215 | $6.52 | $1K | 142,993 |
| 2023-04-18 | Chu Yu-Waye Chief Medical Officer | Sale 10b5-1 | −2,317 | $6.58 | $15K | 140,676 |
Page 6 of 8 · 144 trades